Academic Editor:Ioannis Chatzistefanou, Aristotele University of Thessaloniki (A.U.Th)
Checked for plagiarism: Yes
Fibrous Dysplasia of the Thyroid Cartilage – A Case Study and Review of the Literature
Fibrous dysplasia is a rare disorder of bone that is uncommon in the head and neck region. Herein, we present a rare case of polyostotic fibrous dysplasia involving the right temporal bone and thyroid cartilage in a 19-year-old male. This unique location necessitates close surveillance due to the proximity to the airway and the potential for malignant degeneration.
Fibrous dysplasia is a rare bone disease that produces 2.5% of all bony tumours and over 7% of all non-malignant tumours of bone. We present an uncommon case of polyostotic fibrous dysplasia with involvement of the thyroid cartilage. The clinical features, etiology, histological and radiological features, and treatment of fibrous dysplasia are reviewed.
We report a case of a 19 year old gentleman with no significant past medical or family history of note, who first presented with right-sided headache of 1 month duration. CT scan showed focal bony thickening involving the right squamous temporal bone and greater wing of the sphenoid with internal ground-glass appearance, consistent with focal fibrous dysplasia. He re-presented 5 months later with right-sided cervical lymphadenopathy of 1-month duration. Fine needle aspiration cytology showed necrosis with mild acute inflammation. CT scan revealed right-sided suppurative cervical lymph nodes at levels 2 and 3, with an incidental finding of bilateral lamella expansions of the thyroid cartilage with cystic changes on the left, consistent with fibrous dysplasia. Cultures from the aspirate were positive for mycobacterium tuberculosis and the patient was treated with 6 months of anti-tuberculous chemotherapy. He has been followed-up for a 3 year duration, and has since remained well, with no further complaints of headache, neck pain or swelling.
Fibrous dysplasia is a non-neoplastic, primary disorder of bone, in which normal medullary bone is replaced with abnormal and structurally weak fibrous and osseous tissue. It is divided into 3 major types: monostotic, involving a single bone; polyostotic, involving multiple bones; and McCune Albright syndrome, a polyostotic form of fibrous dysplasia associated with skin pigmentation and precocious puberty in females.
Fibrous dysplasia presents in children and adolescents, with an average age of onset of 10 years. It manifests as slowly enlarging, painless bony masses. Fibrous dysplasia is relatively rare in the craniofacial region (only 20% of all locations) and most commonly involves the maxilla and mandible (83.3%)1. To our knowledge, there has been no previous reported case of fibrous dysplasia involving the laryngeal cartilages. The unique location of the tumour in our patient necessitates close follow-up due to the risk of airway compression.
Fibrous dysplasia is caused by a postzygotic somatic mutation of the GNAS1 gene. This mutation constitutively activates the alpha subunit of the stimulatory G protein (G1), which in turn activates adenylate cyclase. This leads to the formation of cyclic AMP which activates intracellular processes, causing cellular proliferation of endocrine tissues and the bony lesions of fibrous dysplasia. Increased expression of the c-fos proto-oncogene, presumably a consequence of increased adenylate cyclase activity, may be important in the pathogenesis of the bone lesions in patients with fibrous dysplasia2. Acquisition of the activating mutation early in life leads to a more generalized distribution of the mosaicism and is associated with the classic clinical triad of polyostotic fibrous dysplasia, endocrine hyperfunction, and cafe au lait skin lesions described in McCune-Albright syndrome. Acquisition of a similar activating mutation in GNAS1 later in life is associated with the development of isolated lesions (for example, fibrous dysplasia, pituitary or thyroid tumors)3. This mutation has been found in the blood, liver and heart in some patients, and cardiac arrhythmias and hepatic disorders have been reported in conjunction with fibrous dysplasia.
Malignant degeneration occurs in 0.5% of cases of fibrous dysplasia. Malignancies are almost exclusively osteosarcoma. Malignant degeneration is greatest in males with polyostotic disease. In monostotic disease, the incidence of malignant degeneration is highest in craniofacial lesions. Radiotherapy increases the risk by 400 times5, 6. The clinical signs of developing malignancy are pain, rapid swelling, and elevation of alkaline phosphatase levels.
In fibrous dysplasia, there is replacement of lamellar bone with an abnormal metaplastic version of immature woven bone. There is a matrix of whorls of fibrous tissue surrounding irregular spicules of immature woven bone. The fibrous component is similar to the fibrous stroma of normal immature bone, but the osseous component has irregular borders and lacks the osteoblastic rimming typical of normal bony trabeculae. The irregular, misshapen trabaculae form odd geometric patterns and are described as “chinese letters”. In polyostotic fibrous dysplasia, small islands of cartilage are found within the fibrous matrix.
Fries4 distinguished three types of radiographic appearance for fibrous dysplasia: (1) Pagetoid (56%); (2) Sclerotic (23%); and (3) Cystic (21%).
Pagetoid is the most common and is a mixture of types 2 and 3, with a similar appearance to Paget’s disease of bone. These lesions have a “ground glass” appearance with coexisting radiodense and radiolucent areas, due to spicules of new bone. Pagetoid lesions often involve the calvarium. Sclerotic lesions are homogenously dense, while cystic lesions show radiolucency surrounded by a dense rim.
CT reveals a non-homogenous thickening of bone with no soft tissue component. It is helpful in distinguishing fibrous dysplasia from malignancy. Features include osteolysis, destruction of sclerotic lesions, and cortical destruction with soft tissue extension. On T1 MRI, the lesions are non-homogenous with intermediate signal intensity. On T2 MRI, the lesions are non-homogenous with high signal intensity.
Medical treatment includes correction of any underlying endocrine disturbances. In upper extremity lesions, more than 80% respond to non-surgical management. Vitamin D and bisphosphonates (after physeal closure) may help in ameliorating pain and possibly in reconstituting lesions with normal bone. Cortisone has been reported to produce some relief in the pain of bone lesions. Aluminum acetate has been used to precipitate phosphate in the bowel and thus reduce the danger of hyperphosphatemia associated with severe forms of fibrous dysplasia. Hormone therapy has little effect on the course of the disease. Radiotherapy is contraindicated as it increases the risk of malignant degeneration by 400 times5, 6. Expectant management is based on the possibility that the disease process will quiescent at the onset of puberty.
Indications for surgery are deformity, pathological fractures, pain, compromise of function, and malignancy. Surgical options include conservative bone shaving or radical excision with reconstruction. Surgery may reduce the dangers to vision, hearing, speech or airway caused by the encroachment of tumors.
Fibrous dysplasia is a rare bone disease which is usually asymptomatic; however its clinical behavior can be severe due to local growth and malignant degeneration. We present a rare case of fibrous dysplasia of the thyroid cartilage. The unique location of this tumour necessitates close follow-up due to the potential for airway compromise and malignant degeneration.